

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation (GO:0006956) | 8.44555954 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 7.16794532 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.58194525 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.45730508 |
| 5 | glomerular filtration (GO:0003094) | 6.22998477 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.20024731 |
| 7 | protein activation cascade (GO:0072376) | 6.11101126 |
| 8 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.74878807 |
| 9 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.74878807 |
| 10 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.74878807 |
| 11 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.70937227 |
| 12 | renal filtration (GO:0097205) | 5.62136399 |
| 13 | humoral immune response (GO:0006959) | 5.06607726 |
| 14 | regulation of respiratory burst (GO:0060263) | 4.97533706 |
| 15 | type I interferon signaling pathway (GO:0060337) | 4.75006483 |
| 16 | cellular response to type I interferon (GO:0071357) | 4.75006483 |
| 17 | response to type I interferon (GO:0034340) | 4.72120659 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.68826542 |
| 19 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.64271963 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.53347089 |
| 21 | detection of bacterium (GO:0016045) | 4.45623171 |
| 22 | detection of other organism (GO:0098543) | 4.38622671 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.08302115 |
| 24 | antimicrobial humoral response (GO:0019730) | 4.03167264 |
| 25 | antibacterial humoral response (GO:0019731) | 3.96238186 |
| 26 | retina homeostasis (GO:0001895) | 3.91344460 |
| 27 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.86320203 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.81958214 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81958214 |
| 30 | germinal center formation (GO:0002467) | 3.75401166 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.74371830 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 3.74028750 |
| 33 | cellular response to interferon-gamma (GO:0071346) | 3.71430424 |
| 34 | B cell mediated immunity (GO:0019724) | 3.64595154 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 3.63869875 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.57880275 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.53868591 |
| 38 | response to interferon-gamma (GO:0034341) | 3.53690336 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46378206 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.46378206 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46378206 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46378206 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46378206 |
| 44 | modulation by symbiont of host immune response (GO:0052553) | 3.46378206 |
| 45 | myeloid dendritic cell differentiation (GO:0043011) | 3.45691140 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40525145 |
| 47 | myeloid dendritic cell activation (GO:0001773) | 3.32760100 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.29845586 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.25290984 |
| 50 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.20697933 |
| 51 | T-helper 1 type immune response (GO:0042088) | 3.18642439 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17326448 |
| 53 | response to interferon-beta (GO:0035456) | 3.10103761 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09937679 |
| 55 | surfactant homeostasis (GO:0043129) | 3.09800376 |
| 56 | regulation of cellular extravasation (GO:0002691) | 3.05800006 |
| 57 | immune response-activating signal transduction (GO:0002757) | 3.05706783 |
| 58 | negative regulation of myotube differentiation (GO:0010832) | 2.99986479 |
| 59 | negative regulation of bone resorption (GO:0045779) | 2.97155584 |
| 60 | activation of immune response (GO:0002253) | 2.91616490 |
| 61 | cellular extravasation (GO:0045123) | 2.91489891 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.86957332 |
| 63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85107088 |
| 64 | response to host immune response (GO:0052572) | 2.85107088 |
| 65 | production of molecular mediator of immune response (GO:0002440) | 2.83542250 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 2.82672442 |
| 67 | positive regulation of type 2 immune response (GO:0002830) | 2.82345766 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78791441 |
| 69 | detection of biotic stimulus (GO:0009595) | 2.78053909 |
| 70 | positive thymic T cell selection (GO:0045059) | 2.77883853 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 2.77442418 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 2.73244793 |
| 73 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.72920556 |
| 74 | T cell costimulation (GO:0031295) | 2.71681566 |
| 75 | response to host (GO:0075136) | 2.69592113 |
| 76 | response to host defenses (GO:0052200) | 2.69592113 |
| 77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69592113 |
| 78 | response to interferon-alpha (GO:0035455) | 2.69072625 |
| 79 | regulation of integrin activation (GO:0033623) | 2.69062646 |
| 80 | T cell migration (GO:0072678) | 2.69044190 |
| 81 | lymphocyte costimulation (GO:0031294) | 2.67721847 |
| 82 | B cell homeostasis (GO:0001782) | 2.67304779 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.63915687 |
| 84 | dendritic cell differentiation (GO:0097028) | 2.59546407 |
| 85 | Golgi transport vesicle coating (GO:0048200) | 2.57530569 |
| 86 | COPI coating of Golgi vesicle (GO:0048205) | 2.57530569 |
| 87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.56797713 |
| 88 | mature B cell differentiation involved in immune response (GO:0002313) | 2.56618925 |
| 89 | positive regulation of interferon-alpha production (GO:0032727) | 2.55173721 |
| 90 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.54862396 |
| 91 | positive regulation of neutrophil migration (GO:1902624) | 2.54862396 |
| 92 | regulation of tolerance induction (GO:0002643) | 2.54267646 |
| 93 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.54101592 |
| 94 | interferon-gamma secretion (GO:0072643) | 2.53629705 |
| 95 | negative thymic T cell selection (GO:0045060) | 2.50772542 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49847739 |
| 97 | defense response to protozoan (GO:0042832) | 2.49100022 |
| 98 | respiratory burst (GO:0045730) | 2.48954271 |
| 99 | cellular response to interferon-beta (GO:0035458) | 2.46724649 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.7694380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.29953383 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.50473135 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.34123126 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.45864560 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.54496974 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.33449707 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.17909421 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.12946024 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.95683936 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.68183654 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62092506 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51117930 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49547833 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42077906 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38089260 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29875619 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.28078515 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.23986066 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23471175 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21877385 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11044073 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08807172 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06706934 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.05776251 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96431439 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82523973 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.81180341 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80801519 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79842238 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79504824 |
| 31 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66528104 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61927055 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.60097294 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59019743 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58698736 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53191392 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48432771 |
| 38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46973492 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46113531 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44873210 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44249418 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40849000 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40595240 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38280464 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34709755 |
| 46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34697929 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33530287 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32119166 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28864780 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28209480 |
| 51 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22329131 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21766420 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21316403 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20310200 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19063777 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16902928 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16218254 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14284245 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12671670 |
| 60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12553434 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11244265 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07604625 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05894022 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05266355 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04366934 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03917805 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02150574 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00417974 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99684132 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 0.99427511 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97501690 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96950506 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96840774 |
| 74 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96836110 |
| 75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96281193 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94203387 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93566223 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93160179 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92985974 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92801341 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92150819 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89489743 |
| 83 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89315585 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89237833 |
| 85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88557547 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88507113 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.87987525 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87867785 |
| 89 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85366232 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83395934 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.83129697 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82331947 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82307593 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81555691 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79749431 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78780137 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78485552 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77035855 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76726400 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.76194988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.62738322 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.06459962 |
| 3 | MP0003303_peritoneal_inflammation | 3.95203892 |
| 4 | MP0000685_abnormal_immune_system | 3.47267566 |
| 5 | MP0005387_immune_system_phenotype | 3.36914819 |
| 6 | MP0001790_abnormal_immune_system | 3.36914819 |
| 7 | MP0001800_abnormal_humoral_immune | 3.14886868 |
| 8 | MP0003436_decreased_susceptibility_to | 3.14048530 |
| 9 | MP0005671_abnormal_response_to | 3.06191603 |
| 10 | MP0005025_abnormal_response_to | 2.71791042 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.67475815 |
| 12 | MP0009785_altered_susceptibility_to | 2.58983996 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.49385758 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.37342393 |
| 15 | MP0002723_abnormal_immune_serum | 2.36306945 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.32821021 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.31264680 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.23370078 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.22359037 |
| 20 | MP0001819_abnormal_immune_cell | 2.18645643 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.17969960 |
| 22 | MP0002419_abnormal_innate_immunity | 2.13405079 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.04912912 |
| 24 | MP0005275_abnormal_skin_tensile | 2.04559245 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.00704282 |
| 26 | MP0004947_skin_inflammation | 1.94315312 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.89625622 |
| 28 | MP0001873_stomach_inflammation | 1.77475839 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.74890668 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.73600130 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.70329576 |
| 32 | MP0005166_decreased_susceptibility_to | 1.69665975 |
| 33 | MP0002398_abnormal_bone_marrow | 1.68151009 |
| 34 | MP0000716_abnormal_immune_system | 1.67233237 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.66740349 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.64650825 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.58668346 |
| 38 | MP0005310_abnormal_salivary_gland | 1.54535645 |
| 39 | MP0002006_tumorigenesis | 1.51539673 |
| 40 | MP0000858_altered_metastatic_potential | 1.49561245 |
| 41 | MP0002405_respiratory_system_inflammati | 1.46300327 |
| 42 | MP0003866_abnormal_defecation | 1.45420996 |
| 43 | MP0003448_altered_tumor_morphology | 1.42527622 |
| 44 | MP0003045_fibrosis | 1.42027830 |
| 45 | MP0006082_CNS_inflammation | 1.39265656 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.36429691 |
| 47 | MP0002429_abnormal_blood_cell | 1.35726410 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.35029551 |
| 49 | MP0009278_abnormal_bone_marrow | 1.33876608 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.31721925 |
| 51 | MP0000343_altered_response_to | 1.28413988 |
| 52 | MP0003075_altered_response_to | 1.24792578 |
| 53 | MP0002722_abnormal_immune_system | 1.23646949 |
| 54 | MP0005503_abnormal_tendon_morphology | 1.23623990 |
| 55 | MP0008004_abnormal_stomach_pH | 1.23519920 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.21375994 |
| 57 | MP0005023_abnormal_wound_healing | 1.20360530 |
| 58 | MP0008469_abnormal_protein_level | 1.16542485 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.15054127 |
| 60 | MP0002796_impaired_skin_barrier | 1.07027197 |
| 61 | MP0004510_myositis | 1.05361091 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.03839717 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.02999770 |
| 64 | MP0009764_decreased_sensitivity_to | 1.01331227 |
| 65 | MP0005390_skeleton_phenotype | 1.01050697 |
| 66 | MP0005451_abnormal_body_composition | 1.00591558 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.00539817 |
| 68 | MP0002933_joint_inflammation | 0.99869377 |
| 69 | MP0000604_amyloidosis | 0.99823771 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 0.98882155 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.95583416 |
| 72 | MP0004858_abnormal_nervous_system | 0.94884386 |
| 73 | MP0001663_abnormal_digestive_system | 0.94706243 |
| 74 | MP0003279_aneurysm | 0.92239748 |
| 75 | MP0001216_abnormal_epidermal_layer | 0.91408587 |
| 76 | MP0001851_eye_inflammation | 0.90875278 |
| 77 | MP0005164_abnormal_response_to | 0.90848352 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.88292152 |
| 79 | MP0001545_abnormal_hematopoietic_system | 0.88292152 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.88008387 |
| 81 | MP0002060_abnormal_skin_morphology | 0.87784642 |
| 82 | MP0003091_abnormal_cell_migration | 0.86769481 |
| 83 | MP0002396_abnormal_hematopoietic_system | 0.85096510 |
| 84 | MP0002254_reproductive_system_inflammat | 0.80830110 |
| 85 | MP0003828_pulmonary_edema | 0.80737557 |
| 86 | MP0000249_abnormal_blood_vessel | 0.80161776 |
| 87 | MP0008260_abnormal_autophagy | 0.73548330 |
| 88 | MP0001853_heart_inflammation | 0.70494997 |
| 89 | MP0003795_abnormal_bone_structure | 0.70285883 |
| 90 | MP0003252_abnormal_bile_duct | 0.69750871 |
| 91 | MP0002133_abnormal_respiratory_system | 0.69685346 |
| 92 | MP0005388_respiratory_system_phenotype | 0.69685346 |
| 93 | MP0009763_increased_sensitivity_to | 0.68221637 |
| 94 | MP0000490_abnormal_crypts_of | 0.67351293 |
| 95 | MP0001542_abnormal_bone_strength | 0.66012750 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.65289669 |
| 97 | MP0009931_abnormal_skin_appearance | 0.64386223 |
| 98 | MP0009840_abnormal_foam_cell | 0.63200087 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.63164940 |
| 100 | MP0008874_decreased_physiological_sensi | 0.62653329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 6.53237267 |
| 2 | Agammaglobulinemia (HP:0004432) | 4.96070801 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.81596047 |
| 4 | Abnormality of the prostate (HP:0008775) | 4.69470547 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.68557279 |
| 6 | Recurrent bronchitis (HP:0002837) | 4.62602106 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.27482993 |
| 8 | Vasculitis (HP:0002633) | 4.16979512 |
| 9 | Gastrointestinal stroma tumor (HP:0100723) | 4.04367904 |
| 10 | Increased IgE level (HP:0003212) | 4.00150579 |
| 11 | Premature loss of primary teeth (HP:0006323) | 3.80803191 |
| 12 | Colitis (HP:0002583) | 3.79867814 |
| 13 | Meningitis (HP:0001287) | 3.71143156 |
| 14 | Cellulitis (HP:0100658) | 3.68702170 |
| 15 | Abnormality of B cell number (HP:0010975) | 3.61289914 |
| 16 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.61092757 |
| 17 | Recurrent viral infections (HP:0004429) | 3.58381723 |
| 18 | Skin rash (HP:0000988) | 3.41023255 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.38924637 |
| 20 | B lymphocytopenia (HP:0010976) | 3.35958252 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.30731715 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.28280739 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 3.22841787 |
| 24 | Chronic otitis media (HP:0000389) | 3.19761771 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.18276370 |
| 26 | Malnutrition (HP:0004395) | 3.14854601 |
| 27 | Osteomyelitis (HP:0002754) | 3.13791626 |
| 28 | Recurrent sinusitis (HP:0011108) | 3.11791520 |
| 29 | Leukocytosis (HP:0001974) | 3.10757462 |
| 30 | Urticaria (HP:0001025) | 3.06105094 |
| 31 | Recurrent abscess formation (HP:0002722) | 3.01041532 |
| 32 | Gingivitis (HP:0000230) | 2.96596407 |
| 33 | Abnormality of complement system (HP:0005339) | 2.91155568 |
| 34 | Alopecia of scalp (HP:0002293) | 2.90455214 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.89761746 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.86627496 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.80103206 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.77952157 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76231648 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76231648 |
| 41 | Recurrent pneumonia (HP:0006532) | 2.75960456 |
| 42 | Bronchitis (HP:0012387) | 2.74845738 |
| 43 | Abnormality of male internal genitalia (HP:0000022) | 2.74798383 |
| 44 | Xerostomia (HP:0000217) | 2.74397524 |
| 45 | IgM deficiency (HP:0002850) | 2.72204284 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.72078620 |
| 47 | Emphysema (HP:0002097) | 2.69052784 |
| 48 | Hypergammaglobulinemia (HP:0010702) | 2.66990314 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.66425389 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.64699230 |
| 51 | Glomerulonephritis (HP:0000099) | 2.64160349 |
| 52 | Recurrent lower respiratory tract infections (HP:0002783) | 2.59926568 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.57430186 |
| 54 | Complement deficiency (HP:0004431) | 2.54391687 |
| 55 | Myositis (HP:0100614) | 2.53141737 |
| 56 | Hemoptysis (HP:0002105) | 2.50976059 |
| 57 | Skin ulcer (HP:0200042) | 2.49715835 |
| 58 | Recurrent skin infections (HP:0001581) | 2.48605524 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44979686 |
| 60 | Obstructive lung disease (HP:0006536) | 2.43304872 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43304872 |
| 62 | Nasal polyposis (HP:0100582) | 2.40804502 |
| 63 | Orchitis (HP:0100796) | 2.40801999 |
| 64 | Nephritis (HP:0000123) | 2.38426863 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.38007994 |
| 66 | Verrucae (HP:0200043) | 2.34531527 |
| 67 | Papilloma (HP:0012740) | 2.34531527 |
| 68 | IgA deficiency (HP:0002720) | 2.31930550 |
| 69 | Periodontitis (HP:0000704) | 2.29427028 |
| 70 | Abnormality of T cells (HP:0002843) | 2.27443817 |
| 71 | Polygenic inheritance (HP:0010982) | 2.27087213 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.25611886 |
| 73 | Lymphopenia (HP:0001888) | 2.25466221 |
| 74 | Erythema (HP:0010783) | 2.23200589 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23113556 |
| 76 | Villous atrophy (HP:0011473) | 2.23104331 |
| 77 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.23104331 |
| 78 | Ankyloglossia (HP:0010296) | 2.22646407 |
| 79 | Hypermelanotic macule (HP:0001034) | 2.19878451 |
| 80 | Ridged nail (HP:0001807) | 2.19165140 |
| 81 | Thick nail (HP:0001805) | 2.18728427 |
| 82 | Sepsis (HP:0100806) | 2.18552941 |
| 83 | Increased IgM level (HP:0003496) | 2.17171078 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.16938023 |
| 85 | Optic neuritis (HP:0100653) | 2.16938023 |
| 86 | Neoplasm of the lung (HP:0100526) | 2.15505291 |
| 87 | Chest pain (HP:0100749) | 2.14798223 |
| 88 | Restrictive lung disease (HP:0002091) | 2.13960817 |
| 89 | Abnormality of T cell number (HP:0011839) | 2.13725148 |
| 90 | Chronic diarrhea (HP:0002028) | 2.12640693 |
| 91 | Atrophic scars (HP:0001075) | 2.10456878 |
| 92 | Pustule (HP:0200039) | 2.08677313 |
| 93 | Granulocytopenia (HP:0001913) | 2.07749626 |
| 94 | Cheilitis (HP:0100825) | 2.04157039 |
| 95 | Fragile skin (HP:0001030) | 2.01189535 |
| 96 | Chronic sinusitis (HP:0011109) | 1.99198457 |
| 97 | Viral hepatitis (HP:0006562) | 1.99043363 |
| 98 | Right ventricular cardiomyopathy (HP:0011663) | 1.98272888 |
| 99 | Abnormality of primary teeth (HP:0006481) | 1.97824616 |
| 100 | Encephalitis (HP:0002383) | 1.97779101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.76854317 |
| 2 | MAP4K1 | 3.88992922 |
| 3 | TYK2 | 3.71226670 |
| 4 | FGFR4 | 3.68415418 |
| 5 | RIPK4 | 3.55911398 |
| 6 | BLK | 3.21294670 |
| 7 | MST1R | 3.04471109 |
| 8 | KIT | 2.93614240 |
| 9 | PRPF4B | 2.88116256 |
| 10 | JAK1 | 2.66112872 |
| 11 | EPHA3 | 2.53838676 |
| 12 | MAP3K14 | 2.40023825 |
| 13 | IKBKE | 2.24613878 |
| 14 | FGFR3 | 2.22491906 |
| 15 | JAK3 | 2.07353035 |
| 16 | EPHB1 | 1.85892538 |
| 17 | TBK1 | 1.76204120 |
| 18 | CDC42BPA | 1.75904371 |
| 19 | RIPK1 | 1.75060623 |
| 20 | MAP3K13 | 1.74388961 |
| 21 | SMG1 | 1.68595239 |
| 22 | IRAK4 | 1.61653465 |
| 23 | SYK | 1.54260997 |
| 24 | CSF1R | 1.53152874 |
| 25 | LYN | 1.36306964 |
| 26 | CSK | 1.32291608 |
| 27 | TGFBR1 | 1.31555855 |
| 28 | JAK2 | 1.28912834 |
| 29 | MATK | 1.28653885 |
| 30 | FES | 1.28410936 |
| 31 | IRAK1 | 1.21604490 |
| 32 | ZAP70 | 1.21564533 |
| 33 | TXK | 1.19929467 |
| 34 | NEK9 | 1.15292060 |
| 35 | MAP3K1 | 1.09185411 |
| 36 | GRK6 | 1.07852126 |
| 37 | NME2 | 1.05481773 |
| 38 | DDR2 | 1.05106691 |
| 39 | SIK3 | 1.03773753 |
| 40 | IKBKB | 1.02490751 |
| 41 | EIF2AK3 | 0.99308433 |
| 42 | STK24 | 0.95201780 |
| 43 | BMPR2 | 0.93737493 |
| 44 | FER | 0.87587490 |
| 45 | LRRK2 | 0.86743700 |
| 46 | PDGFRA | 0.80685682 |
| 47 | BTK | 0.79457651 |
| 48 | PIK3CA | 0.79130057 |
| 49 | TRIB3 | 0.77950795 |
| 50 | MAPK7 | 0.77616549 |
| 51 | NLK | 0.76896036 |
| 52 | HIPK2 | 0.76883086 |
| 53 | HCK | 0.75818411 |
| 54 | FGR | 0.75402632 |
| 55 | LCK | 0.74021959 |
| 56 | MAP3K10 | 0.73094242 |
| 57 | MET | 0.60417091 |
| 58 | MAPK11 | 0.59588999 |
| 59 | CDK19 | 0.58645372 |
| 60 | PKN2 | 0.57208844 |
| 61 | MAPKAPK2 | 0.55938412 |
| 62 | PDPK1 | 0.54657623 |
| 63 | DMPK | 0.53367483 |
| 64 | TESK2 | 0.53216927 |
| 65 | PDK1 | 0.52977665 |
| 66 | EPHA2 | 0.52818094 |
| 67 | NME1 | 0.51885923 |
| 68 | TAF1 | 0.50618887 |
| 69 | MAP3K3 | 0.48999246 |
| 70 | TAOK3 | 0.48087401 |
| 71 | FYN | 0.48008528 |
| 72 | RET | 0.47689955 |
| 73 | KSR2 | 0.44357317 |
| 74 | CDK9 | 0.44100462 |
| 75 | IRAK3 | 0.42935923 |
| 76 | MELK | 0.42182074 |
| 77 | CHUK | 0.40514805 |
| 78 | TAOK1 | 0.40381625 |
| 79 | KDR | 0.37577687 |
| 80 | PRKCQ | 0.36512874 |
| 81 | ALK | 0.36113618 |
| 82 | PRKCD | 0.34976603 |
| 83 | MAP3K6 | 0.34106143 |
| 84 | MAPK4 | 0.33893162 |
| 85 | YES1 | 0.33683380 |
| 86 | CDK6 | 0.32987487 |
| 87 | CDK12 | 0.31403450 |
| 88 | TAOK2 | 0.31015198 |
| 89 | GRK5 | 0.30672301 |
| 90 | ARAF | 0.27616938 |
| 91 | SCYL2 | 0.27084366 |
| 92 | ABL1 | 0.27014646 |
| 93 | CDK4 | 0.26960317 |
| 94 | IGF1R | 0.26325852 |
| 95 | PTK6 | 0.24032330 |
| 96 | TEC | 0.23350142 |
| 97 | ITK | 0.23070885 |
| 98 | MAP3K11 | 0.22581149 |
| 99 | MAPK3 | 0.22472604 |
| 100 | MAP2K3 | 0.20592664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.91394429 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.83676743 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.71525649 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.71110297 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.54663051 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.51855861 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.01483624 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.97564665 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.71157375 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.70690050 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.62947622 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.46790735 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 2.05977330 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96139358 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.92439909 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74796051 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74104300 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73271147 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.68714484 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.66175724 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62904254 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53542320 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.42574829 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36526378 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.33341197 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32152633 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.29683778 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25962075 |
| 29 | Hepatitis C_Homo sapiens_hsa05160 | 1.21940032 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17301740 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11119008 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09743995 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06991178 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05675563 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03518950 |
| 36 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02001566 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99394959 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96135413 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93834518 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 0.86725216 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.86364441 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85220413 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84852841 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82414121 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81227644 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81024156 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73254320 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72014163 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71850638 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71363326 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71310936 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.67836264 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66580270 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64614502 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64529220 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.63367761 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62768869 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55064601 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51676758 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50827840 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50280157 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.49864777 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.48325953 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47801828 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47490679 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.46175183 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44517348 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44085027 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40697003 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.40074218 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39832603 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39762444 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39004765 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38539779 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38255115 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38230576 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.38129061 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34773022 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33417162 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32924207 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.32639936 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30463743 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26177716 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25669781 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25260978 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24386664 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.24261211 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22928952 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22041933 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.21914614 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17690790 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17243676 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15759997 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.15672453 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.15380170 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13497783 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.13443651 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.12622390 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10941408 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10922450 |

